- Home
- About Us
- Service
- Application
- Technology
- Resource
- Contact Us
News and Events
HaploX to Launch Atera-Powered Spatial Transomics Services Globally in Q3 2026
2026-05-06
HaploX Biotech Co., Ltd. is pleased to announce that it will officially launch next-generation high-throughput spatial transcriptomics services powered by the 10x Genomics Atera platform for global academic, medical, and biopharmaceutical partners in Q3 2026.
As 10x Genomics’ latest revolutionary spatial biology platform, Atera unifies whole-transcriptome coverage, single-cell–equivalent sensitivity, and high-throughput scalability—eliminating traditional trade-offs to deliver transformative solutions for oncology, immunology, developmental biology, neuroscience, and translational research.
Leveraging the core performance of the Atera platform, HaploX provides global clients with standardized, one-stop spatial multi-omics research services to precisely map in situ gene expression and cellular spatial distribution, enabling research teams to efficiently generate high-quality, publication-ready results.
HaploX delivers end-to-end standardized services covering sample preparation, experimental processing, high-throughput data analysis, professional interpretation, and interactive reporting. Backed by strict quality control, we ensure reliable data and efficient project delivery to empower global life science research and medical innovation. Scheduled for official launch in Q3 2026, HaploX will continue to expand its spatial multi-omics portfolio and provide professional, efficient, and trusted solutions to drive breakthrough discoveries for research partners worldwide.
